Carlos Linn, MD, serves as the Director and Global Lead Clinician for Oncology/Hematology in Global Clinical Development at Pfizer, where they focus on strategic planning, clinical development, and medical oversight for oncology studies. Previously, they held various roles, including Director of Clinical Development Lead in China and Chief Principal Physician at the Memorial Lo-Hsu Foundation Cancer Center. Carlos has extensive experience in managing clinical trials and safety surveillance for breakthrough therapies in oncology and hematology. They earned their Doctor of Medicine (M.D.) from National Yang Ming University in 1993.
This person is not in the org chart
This person is not in any teams
This person is not in any offices